Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites

Clinical trial NCT03665610 · COMPLETED

Trial details

NCT number: NCT03665610
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Healthy Volunteers

Start date: 2018-09-10
Primary completion: 2019-01-10
Enrollment: 212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.